SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co.
MTC 2.930-3.6%12:15 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony Wong who wrote (1530)3/8/1999 8:40:00 PM
From: Dan Spillane   of 2539
 
(Pipeline updated, says) "As indicated in the pipeline below, we anticipate potential launches for more than two dozen products in the four-year period 1999-2002. The overall expected value of this near-term portfolio is more than $10 billion."

NOTE the first product the organic industry wants to stop (because it can't compete) is the healthier oil coming out next year:

(Yr 2000)
High-Stearate Soybean and Canola Oils
Created by modified soybean and canola plants, these functional oils offer more healthful properties for margarines and shortenings.

(full text)
monsanto.com

...also note the "SC-" drugs have now been given names; they are real drugs in the pipeline at this point.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News